2022
DOI: 10.1055/s-0042-1747591
|View full text |Cite
|
Sign up to set email alerts
|

Therapieeffekt und und nasale Biomarkerexpression unter Dupilumab bei der schweren chronischen Rhinosinusitis mit Polyposis (CRSwNP): Ergebnisse nach 3 Monaten Therapie

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles